Also greater number of CD8+ T cells in cancer stroma was found in NSCLC patients with lymph node metastases compared to NSCLC patients without lymph node metastases (P < 0.05) (Table 3). This evidence concerns the gene CD8A and metastatic malignant neoplasm in the lymph nodes.